Cargando…

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

Detalles Bibliográficos
Autores principales:	Hwang, Seonghwan, Kim, Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293615/ https://www.ncbi.nlm.nih.gov/pubmed/35850496 http://dx.doi.org/10.3350/cmh.2022.0143

Ejemplares similares

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
por: Cho, Ye Eun, et al.
Publicado: (2023)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Crystal Ball
por: Fuchs, Andreas
Publicado: (2020)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
por: Ren, Tian-Yi, et al.
Publicado: (2021)

Neuropathy: The Crystal Ball for Cardiovascular Disease?
por: Vinik, Aaron I., et al.
Publicado: (2010)

Crystal Ball at the IAA
por: Reichenbach, Michael
Publicado: (2021)

It’s Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging
por: Joo, Sae Kyung, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

Treating Nonalcoholic Fatty Liver Disease From the Outside In?
por: Flynn, Charles R.
Publicado: (2019)

Imaging methods in the assessment of nonalcoholic fatty liver disease
por: Parente, Daniella Braz
Publicado: (2020)

Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Inside the Crystal Ball: How to Make and Use Forecasts
por: Harris, Maury
Publicado: (2014)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
por: Lee, Seung Mi, et al.
Publicado: (2022)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
por: Noh, Junghyun
Publicado: (2020)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Waiting for Multi-Stakeholders̕ Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature
por: Yoon, Eileen L., et al.
Publicado: (2022)

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
por: Idilman, Ilkay S., et al.
Publicado: (2023)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
por: Chun, Ho Soo
Publicado: (2023)

Physician supply forecast: better than peering in a crystal ball?
por: Roberfroid, Dominique, et al.
Publicado: (2009)

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
por: Le, Michael H., et al.
Publicado: (2022)

Is Vitamin E or Ursodeoxycholic Acid a Valid Treatment Option for Nonalcoholic Fatty Liver Disease in 2016?
por: Beaton, Melanie D., et al.
Publicado: (2016)

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Jang, Byoung Kuk
Publicado: (2012)

Nonalcoholic fatty liver disease: One more reason to strengthen public health
por: Alaama, Tareef
Publicado: (2018)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e713uu8mq7hftd31gkvs5rg6qc